References
- Makidonan T, Kay M M B. Age influence of the immune system. Adv Immunol 1980; 29: 287–330
- Bach J F. Immunosenescence. Triangle 1986; 25: 25–31
- Finkelstein M S. Aging immunocytes and immunity. Characteristics and significance (Symposium on hematologic disorders). Clin Geriatr Med 1985; 1: 899–911
- Pandey J P, Fudenberg H M, Ainsowrth S K, Loadholt C B. Autoantibodies in healthy subjects of different age groups. Mech Ageing Dev 1979; 10: 399–405
- Gordon J, Rosenthal M. Failure to detect age-related increase of non-pathological autoantibodies (Letter). Lancet 1984; i: 231
- Silvestris F, Anderson W, Goodwin J S, Williams R C, Jr. Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol 1985; 35: 234–244
- Hallgren H M, Buckley C E, Gilbertsen V A, Yunis E J. Lymphocyte-phytohemagglutin responsiveness, immunoglobulins and autoantibodies in ageing humans. J Immunol 1973; 111: 1101–1107
- Delespesse G, Gausset P H, Sarfati M, Dubi-Rucquou M, Debisschop M J, Van Haelst L. Circulating immune complexes in old people and in diabetics: correlation with autoantibodies. Clin Exp Immunol 1980; 40: 96–102
- Schuller E, Allinquant B, Rebout J, Fournier C, Dardenne M, Bach J F. Immunological studies in human ageing. II. Associated increase in anti-RNA and anti-DNA antibodies. J Clin Lab Immunol 1981; 6: 107–112
- Goodwin J S, Searles R P, Tung K S K. Immunological responses of a healthy elderly population. Clin Exp Immunol 1982; 48: 403–410
- Kasjanov A, Cebecauer L, Balaz V. Antibodies against ss-DNA in persons of various age. Mech Ageing Dev 1984; 28: 289–295
- Hijmans W, Radl J, Bottazzo G F, Doniach D. Autoantibodies in highly aged humans. Mech Ageing Dev 1984; 26: 83–89
- Manoussakis M N, Tzioufas A G, Silk M P, Pange P J E, Goudevenos J, Moutsopoulos H M. High prevalance of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557–565
- Smith K A. Interleukin-2: inception, impact and implications. Science 1988; 240: 1169–1176
- Rubin L A, Kirman C C, Fritz M E, Biddison W E, Boutin B, Yarchoan R, Nelson D L. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172–3177
- Wagner D K, Kiwanuka J, Edwards B K, Rubin L A, Nelson D L, Magrath I T. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. J Clin Oncol 1987; 5: 1262–1274
- Campden D H, Horwitz D A, Quismorio F P, Jr, Ehresmann G R, Martin W J. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activiation. Arthritis Rheum 1988; 31: 1358–1364
- Symons J A, Wood N C, Di Giovine F S, Duff G W. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-l and IL-2 inhibition. J Immunol 1988; 141: 2612–2618
- Manoussakis M N, Papadopoulos G K, Drosos A A, Moutsopoulos H M. Soluble interleukin-2 receptor molecules in the serum of patients with autoimmune diseases. Clin Immunol Immunopathol 1989; 50: 321–332
- Tan E M. Autoantibodies to nuclear antigens (ANA): Their immunobiology and Medicine. Adv Immunol 1982; 33: 167–240
- Rossman I. Mortality and morbidity overview. Clinical Geriatrics, I Rossman. Lipincott, Philadelphia, J.A. 1979
- Moulias R, Proust J, Wang A, Gongy F, Marescot M R, Chabrolle A D, Hamelin A P, Lesourd B. Age-related increase in autoantibodies (Letter). Lancer 1984; ii: 1128–1129
- Delespesse G, Duchateau J, Bastenie P A, Lauvaux J P, Collet H, Covaerts A. Cell-mediated immunity in diabetes mellitus. Clin Exp Immunol 1974; 18: 451–465
- Mascart-Lemone F, Delespesse G, Servais G, Kunstler M. Characterization of immunoregulatory T-lymphocytes during ageing by monoclonal antibodies. Clin Exp Immunol 1982; 48: 148–154
- Chandra R K. (Symposium). Nutritional deficiency, immune responses, and infectious illness. Fed Proc 1980; 39: 3086
- Greene W C, Leonard W J, Depper J M, Nelson D L, Waldmann T A. The human interleukin-2 receptor: Normal and abnormal expression in T-cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med 1986; 105: 560–572
- De Weck A L. Lymphoid cell functions in ageing, A L De Weck. Eurage, RijswijkNetherlands 1984
- Thoman M L, Weigle W O. Deficiency in suppressor T cell activity in aged animals. J Exp Med 1983; 157: 2184–2189
- Parekh R, Roitt I, lsenberg D, Dwek R, Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 1988; 167: 1731–1736
- Gillis S, Kozak R, Durante M, Weksler M E. Immunological studies of aging. Decreased production of and response to T-cell growth factor by lymphocytes from aged humans. J Clin Invest 1981; 67: 937–942
- Gilman S C, Rosenberg J S. FeldmanJD. T-lymphocytes of young and aged rats. II. Functional defects and the role of interleukin-2. J Immunol 1982; 128: 644–650
- Rubin L A, Jay G, Nelson D L. The released interleukin-2 receptor binds interleukin-2 efficiently. J Imniunol 1986; 137: 3821–3844
- Takata H, Suzuki M, lshii T, Sekiguchi S, Iri H. Influence of Major Histocompatibility Complex Region genes on human longevity among Okinawan-Japanese Centenarians and Non-agerians. Lancet 1987; ii: 824–826
- Walford R L. Modem Biological Theories of Ageing, H R Werner, R N Butler, R L Sproff, E L Schneider. Raven Press. 1987; 243–250